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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER2115Platelet Function TestsDiana A. Gorog, Valentin Fuster
This review is a critical evaluation of the usefulness of platelet function tests (PFTs) for aiding
diagnosis, predicting risk, and monitoring therapy. The power of PFTs in predicting
thrombotic events for a given individual is variable and often modest. Alteration of
antithrombotic treatment based on the results of PFTs has not been shown to alter clinical
outcome. PFTs in current mainstream use cannot reliably assess bleeding risk. Having been in
use for over a decade, the hopes raised by PFTs in clinical practice remain unfulfilled.CLINICAL RESEARCH ACUTE CORONARY SYNDROMES2130Frequent Nuisance Bleeding With DAPT After AMIAmit P. Amin, Alok Bachuwar, Kimberly J. Reid, Adnan K. Chhatriwalla, Adam C. Salisbury,
Robert W. Yeh, Mikhail Kosiborod, Tracy Y. Wang, Karen P. Alexander, Kensey Gosch, David J. Cohen,
John A. Spertus, Richard G. Bach
Prolonged dual antiplatelet therapy (DAPT) reduces adverse ischemic events, but increases
the rates of major and minor bleeding. Amin and colleagues investigated the incidence of
even lesser degrees of bleeding and its impact on quality of life (QOL). Nuisance bleeding
was defined as Bleeding Academic Research Consortium (BARC) type 1, “bleeding that does
not cause the patient to seek medical care . . . and is not actionable.” Using data from a large
acute myocardial infarction (AMI) registry, nuisance bleeding occurred in 38% of patients
over 12 months. Nuisance bleeding was independently associated with a decrement in QOL
and a trend toward higher re-hospitalization.
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Jessica J. Jalbert, Soko Setoguchi
Chen and colleagues sought to measure the impact of baseline heart failure (HF) burden on
survival after primary implantable cardioverter-defibrillator (ICD) implantation. Primary ICD
recipients age 66 years with an ejection fraction 35% were identified from Medicare
records and the ICD Registry. The 3-year mortality among the nearly 70,000 ICD recipients
was 31%; 27% among patients with no prior HF hospitalization and 63% in those with 3
prior HF hospitalizations. Mortality at 3 years among the one-half of ICD recipients with no
prior HF hospitalization and same-day implantation (low HF burden) was similar to that in
the landmark clinical trials (22%). Future research to understand the effectiveness of primary
ICD implantation among Medicare beneficiaries with heavy HF burdens appears warranted.Editorial Comment: Rachel Lampert, p. 2151HEART FAILURE AND HEART RHYTHM DISORDERS2153Effect of RV Dysfunction in Patients Referred for CRTThibaud Damy, Stefano Ghio, Alan S. Rigby, Luc Hittinger, Sandra Jacobs, Francisco Leyva,
Juan F. Delgado, Jean-Claude Daubert, Daniel Gras, Luigi Tavazzi, John G. F. Cleland
Damy and colleagues studied the impact of right ventricular (RV) dysfunction on patients
who undergo cardiac resynchronization therapy (CRT). Nearly 700 patients enrolled in the
CARE-HF trial had tricuspid plane systolic excursion (TAPSE) measured at baseline and
one-half then underwent CRT. Overall, CRT left ventricular but not RV structure and
function. During follow-up, patients with lower TAPSE had a higher mortality, but the
reduction in mortality with CRT was similar in each tertile of TAPSE. RV dysfunction is a
powerful determinant of prognosis among candidates for CRT, but does not affect the
prognostic benefits of CRT.HEART FAILURE AND HEART RHYTHM DISORDERS2161Prognostic Implications of RR-NSVT Found on ICD InterrogationJay Chen, George Johnson, Anne S. Hellkamp, Jill Anderson, Daniel B. Mark, Kerry L. Lee,
Gust H. Bardy, Jeanne E. Poole
The clinical implication of implantable cardioverter-defibrillator (ICD)-detected rapid rate
nonsustained ventricular tachycardia (RR-NSVT) identified during routine ICD
interrogations is unclear. Using data from SCD-HeFT, RR-NSVT was documented on ICD
interrogation in 23% of patients. The average duration of RR-NSVT was 26 beats
(7.5 s), with an average cycle length of 259 ms. Polymorphic RR-NSVT accounted for 56%
of episodes. RR-NSVT was independently associated with appropriate ICD shocks (hazard
ratio [HR]: 4.25) and with all-cause mortality (HR: 2.40). These results suggest that RR-
NSVT identified on routine ICD interrogations identifies patients at increased risk for
adverse outcomes.(continued on page A-22)
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nBIOMARKERS IN PERIPHERAL ARTERY DISEASE2169Oxidation-Specific Biomarkers Linked to the Risk of PADMonica L. Bertoia, Jennifer K. Pai, Jun-Hee Lee, Adam Taleb, Michel M. Joosten, Murray A. Mittleman,
Xiaohong Yang, Joseph L. Witztum, Eric B. Rimm, Sotirios Tsimikas, Kenneth J. Mukamal
Bertoia and colleagues studied the association between oxidation-specific biomarkers,
primarily oxidized phospholipids (OxPL) on apolipoprotein B-100–containing lipoproteins
(OxPL/apoB) and lipoprotein (a) [Lp(a)], and the risk of peripheral artery disease (PAD).
The study population included 2 parallel nested case-control studies of men and women with
incident confirmed clinically significant PAD matched 1:3 to controls. Levels of OxPL/apoB
were positively associated with risk of PAD. These results confirm that OxPL/apoB levels
can be used to identify patients at risk of PAD.CONGENITAL HEART DISEASE2180Prevalence and Predictors of Gaps in Care Among Adult CHD PatientsMichelle Gurvitz, Anne Marie Valente, Craig Broberg, Stephen Cook, Karen Stout, Joseph Kay, Jennifer Ting,
Karen Kuehl, Michael Earing, Gary Webb, Linda Houser, Alexander Opotowsky, Amy Harmon,
Dionne Graham, Paul Khairy, Ann Gianola, Amy Verstappen, Michael Landzberg, for the Alliance for Adult
Research in Congenital Cardiology (AARCC) and Adult Congenital Heart Association
Gurvitz and colleagues reviewed a registry from 12 adult congenital heart disease (CHD)
centers to quantify the prevalence of gaps in cardiology care among adult CHD patients. A
3-year gap in care was identified in 42% of the nearly 1,000 patients presenting for the first
time after age 18 years; 8% had a gap longer than a decade. Mean age at first gap was 19.9
years. The first lapse commonly occurred around age 19 years. Common reasons for returning
to care were new symptoms, referral from provider, and desire to prevent problems. Adult
CHD patients commonly have gaps in cardiology care that are often quite long.PRE-CLINICAL RESEARCH PRE-CLINICAL RESEARCH2185Noninvasive Renal Sympathetic Denervation by Extracorporeal HIFU in a Canine ModelQifeng Wang, Rui Guo, Shunkang Rong, Gang Yang, Que Zhu, Yonghong Jiang, Changming Deng,
Dichuan Liu, Qi Zhou, Qi Wu, Shunhe Wang, Jun Qian, Qi Wang, Han Lei, Tong-Chuan He,
Zhibiao Wang, Jing Huang
Wang and colleagues investigated the feasibility of using extracorporeal high-intensity focused
ultrasound (HIFU) for noninvasive renal sympathetic denervation (RSD). Therapeutic
ablations were performed by HIFU on the bilateral renal nerves in a canine model. After
ablation, the blood pressure (BP) and plasma noradrenaline (NA) significantly decreased
compared to the baseline values (BP changes 15.9/13.6 mm Hg, NA change 55.4%
8 days after ablation). Histologic examination revealed the disruption of nerve fibers, necrosis
f Schwann cells and neurons, and apparent denervation on day 28. No procedure-related
omplications were observed. These promising early results suggest the HIFU may offer a
oninvasive method for RSD.
